Alfredo Adán Selected Research

Vascular Endothelial Growth Factors

1/2020

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfredo Adán Research Topics

Disease

35	Uveitis 05/2024 - 03/2009
23	Macular Edema 09/2023 - 01/2013
16	Inflammation (Inflammations) 05/2024 - 10/2010
7	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 03/2009
6	Behcet Syndrome (Behcet's Syndrome) 01/2023 - 01/2013
4	Cataract (Cataracts) 01/2024 - 11/2008
4	Choroidal Neovascularization 02/2019 - 03/2003
3	Macular Degeneration (Age-Related Maculopathy) 12/2024 - 02/2011
3	Posterior Uveitis 01/2023 - 10/2010
3	Infections 10/2022 - 11/2008
3	Rheumatoid Arthritis 01/2020 - 04/2013
3	Neoplasms (Cancer) 01/2020 - 01/2014
3	Retinal Vasculitis 01/2018 - 10/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 10/2022
2	COVID-19 01/2022 - 01/2021
2	Psoriatic Arthritis 01/2020 - 04/2013
2	Ankylosing Spondylitis 01/2020 - 04/2013
2	Panuveitis 01/2018 - 10/2012
2	Vasculitis (Vasculitides) 03/2017 - 10/2014
2	Ischemia 01/2017 - 10/2003
2	Birdshot Chorioretinopathy 01/2017 - 10/2011
2	Necrosis 04/2014 - 10/2013
1	Drug-Related Side Effects and Adverse Reactions 10/2022
1	Atrophy 01/2022
1	Arthritis (Polyarthritis) 11/2021
1	Susac Syndrome 11/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Edema (Dropsy) 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	Multiple Sclerosis 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2019
1	Graves Ophthalmopathy 10/2019
1	Vascular Diseases (Vascular Disease) 10/2019
1	Hemorrhage 02/2019
1	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 02/2019
1	Lymphoma (Lymphomas) 01/2019
1	Eye Diseases (Eye Disease) 10/2017
1	Retinal Vein Occlusion 10/2017
1	Chronic Disease (Chronic Diseases) 10/2017
1	Phlebitis 03/2017
1	Retinal Detachment (Retinal Detachments) 01/2017

Drug/Important Bio-Agent (IBA)

13	tocilizumab (atlizumab)FDA Link 01/2023 - 09/2013
12	Retinaldehyde (Retinal)IBA 04/2024 - 10/2011
11	Adalimumab (Humira)FDA Link 05/2024 - 10/2012
9	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 06/2004
7	CytokinesIBA 09/2021 - 10/2013
7	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021 - 07/2013
6	Infliximab (Remicade)FDA Link 01/2023 - 03/2007
6	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2019 - 11/2013
5	C-Reactive ProteinIBA 01/2022 - 01/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 03/2007
5	Monoclonal AntibodiesIBA 10/2019 - 03/2007
4	Fluocinolone Acetonide (Capex)FDA LinkGeneric 11/2023 - 01/2020
4	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022 - 12/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2013
3	Certolizumab Pegol FDA Link 12/2022 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2014
3	golimumab FDA Link 07/2018 - 04/2013
3	Fluorescein (Funduscein)FDA LinkGeneric 10/2014 - 03/2003
3	InterferonsIBA 04/2014 - 10/2013
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2024 - 10/2022
2	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2017
2	Antinuclear AntibodiesIBA 11/2021 - 06/2014
2	InterleukinsIBA 01/2020 - 10/2013
2	Interleukin-2 (IL2)IBA 10/2013 - 05/2013
2	Bevacizumab (Avastin)FDA Link 12/2007 - 11/2007
1	Biocompatible Materials (Biomaterials)IBA 12/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Antimalarials (Antimalarial Agents)IBA 10/2022
1	AntibodiesIBA 10/2022
1	anti-dsDNA autoantibodyIBA 11/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2021
1	N-acetyltryptophanamide (NATA)IBA 09/2020
1	Vascular Endothelial Growth FactorsIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019
1	GlucocorticoidsIBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 01/2017
1	HLA-DR15 antigenIBA 01/2017
1	P-2 (P 2)IBA 01/2017
1	HLA-DR alpha-ChainsIBA 01/2017
1	Antirheumatic Agents (DMARD)IBA 12/2016
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2016
1	HLA-B51 AntigenIBA 12/2014
1	HLA-B Antigens (HLA-B)IBA 04/2014

Therapy/Procedure

17	Therapeutics 12/2024 - 02/2011
6	Vitrectomy 01/2023 - 03/2003
5	Biological Therapy 01/2021 - 09/2016
3	Injections 01/2021 - 02/2019
3	Intravitreal Injections 01/2020 - 12/2007
2	Intraocular Lenses (Intraocular Lens) 01/2024 - 03/2009
1	Aftercare (After-Treatment) 01/2023
1	Withholding Treatment 10/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Lasers (Laser) 10/2014